Status: Closed

This event is closed to further registrations.

Date, Time & Location

Thursday, Sep 21, 2017

2:00 PM - 3:30 PM Eastern Standard Time


ADAP Advocacy Association

PO Box 15275
Washington, DC  20003



The Community Access National Network (CANN) — in collaboration with the ADAP Advocacy Association — is hosting the 2nd Annual National Monitoring Report on HIV/HCV Co-Infection. The community roundtable is being held on Thursday, September 21st at 2:00pm at PhRMA’s offices in Washington, DC. Remote access will also be offered for HIV/HCV stakeholders who cannot attend the meeting in-person.

At the meeting, CANN will present its annual report on the state of co-infection in the United States, including a summary of the HIV/HCV Co-Infection Watch. In addition, NASTAD will present an update on its Access to Care and Treatment for HCV Mono-Infection and HIV/HCV Co-Infection.


The event is sponsored by the ADAP Advocacy Association, Gilead Sciences, Merck, Quest Diagnostics, Walgreens, and the Pharmaceutical Research and Manufacturers of America (PhRMA).

The event is FREE, but advance registration is required to attend. Seating is limited.

Remote participation is also being offered to stakeholders outside of the Washington, DC area.

HIV/HCV Co-Infection Watch

Cancellation Policy